Single-component nanoagents with large Stokes shift for high-effect phototheranostics
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Photodynamic Therapy Research Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. Polyprodrug nanomedicines: an emerging paradigm for cancer therapy
2. Design of superior phototheranostic agents guided by Jablonski diagrams10.1039/D0CS00671H ↗
3. Biogenic cluster-encased gold nanorods as a targeted three-in-one theranostic nanoenvelope for SERS-guided photochemotherapy against metastatic melanoma10.1021/acsabm.8b00746 ↗
4. GOx-assisted synthesis of pillar[5]arene based supramolecular polymeric nanoparticles for targeted/synergistic chemo-chemodynamic cancer therapy10.1186/s12951-021-01237-0 ↗
5. Triphenylamine flanked boron difluoride formazanate for NIR-II fluorescence imaging-guided photothermal therapy10.1016/j.dyepig.2022.110478 ↗
6. Recent development of pH-responsive theranostic nanoplatforms for magnetic resonance imaging-guided cancer therapy10.1002/EXP.20220002 ↗
7. Boosting fluorescence-photoacoustic-Raman properties in one fluorophore for precise cancer surgery10.1016/j.chempr.2019.07.015 ↗
8. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy10.1016/j.biomaterials.2022.121906 ↗
9. A small-molecule based organic nanoparticle for photothermal therapy and near-infrared-IIb imaging10.1021/acsami.2c11706 ↗
10. Semiconducting polymer nanoparticles with intramolecular motion-induced photothermy for tumor phototheranostics and tooth root canal therapy10.1002/adma.202200179 ↗
11. Metabolizable photosensitizer with aggregation-induced emission for photodynamic therapy10.1021/acs.chemmater.1c01173 ↗
12. Albumin-based therapeutics capable of glutathione consumption and hydrogen peroxide generation for synergetic chemodynamic and chemotherapy of cancer10.1021/acsnano.1c08536 ↗
13. Icing on the cake: combining a dual PEG-functionalized pillararene and an A-D-A small molecule photosensitizer for multimodal phototherapy10.1007/s11426-022-1232-9 ↗
14. A nanoplatform for mild-temperature photothermal and type I & II photodynamic therapy in the NIR-II biowindow10.1039/D2CC03248A ↗
15. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy10.1186/s12951-022-01531-5 ↗
16. Diketopyrrolopyrrole derivatives-based NIR-II fluorophores for theranostics10.1016/j.dyepig.2021.109480 ↗
17. Crucial breakthrough of second near-infrared biological window fluorophores: design and synthesis toward multimodal imaging and theranostics10.1039/C8CS00234G ↗
18. An oral ratiometric NIR-II fluorescent probe for reliable monitoring of gastrointestinal diseases in vivo10.1016/j.biomaterials.2022.121956 ↗
19. Versatile types of inorganic/organic NIR-IIa/IIb fluorophores: from strategic design toward molecular imaging and theranostics10.1021/acs.chemrev.1c00553 ↗
20. Molecular programming of NIR-IIb-emissive semiconducting small molecules for in vivo high-contrast bioimaging beyond 1500 nm10.1002/adma.202201263 ↗
21. Near-infrared luminescence high-contrast in vivo biomedical imaging10.1038/s44222-022-00002-8 ↗
22. A “dual-source, dual-activation” strategy for an NIR-II window theranostic nanosystem enabling optimal photothermal-ion combination therapy10.1002/smll.202201179 ↗
23. Rational design of high brightness NIR-II organic dyes with S-D-A-D-S structure10.1021/accountsmr.0c00114 ↗
24. Design of one-for-all near-infrared aggregation-induced emission nanoaggregates for boosting theranostic efficacy10.1021/acsnano.2c10661 ↗
25. De novo design of reversibly pH-switchable NIR-II aggregation-induced emission luminogens for efficient phototheranostics of patient-derived tumor xenografts10.1021/jacs.2c10076 ↗
26. Precise examination of peripheral vascular disease for diabetics with a novel multiplexed NIR-II fluorescence imaging Technology10.1016/j.nantod.2022.101378 ↗
27. Surface plasmon-enhanced NIR-II fluorescence in a multilayer nanoprobe for through-skull mouse brain imaging10.1021/acsami.2c11218 ↗
28. Tumor-microenvironment-Activated NIR-II nanotheranostic platform for precise diagnosis and treatment of colon cancer10.1021/acsami.2c04242 ↗
29. Rational design of conjugated photosensitizers with controllable photoconversion for dually cooperative phototherapy10.1002/adma.201801216 ↗
30. Asymmetric small organic molecule-based NIR-II fluorophores for high performance tumor phototheranostics10.1039/D1QM00472G ↗
31. Photoactive oligomer with an acceptor–donor–acceptor-conjugated structure for single near-infrared light-triggered photothermal/photodynamic synergistic therapy of tumors10.1021/acsapm.2c02016 ↗
32. Polymer dots for precision photothermal therapy of brain tumors in the second near-infrared window: a mini-review10.1021/acsapm.0c00715 ↗
33. Unadulterated organic nanoparticles with small sizes for robust tumor imaging and photothermal treatment10.1002/adfm.202103714 ↗
34. State-of-the-art self-luminescence: a win–win situation10.1039/D2CS00228K ↗
35. Supramolecular J-aggregates of aza-BODIPY by steric and π–π nteractions for NIR-II phototheranostics10.1039/D1TB02820K ↗
36. Self-assembled porphyrin polymer nanoparticles with NIR-II emission and highly efficient photothermal performance in cancer therapy
37. A hypoxia-activated photothermal agent inhibits multiple heat shock proteins for low-temperature photothermal therapy10.1039/D2CC06598C ↗
38. Coordinating the mechanisms of action of ferroptosis and the photothermal effect for cancer theranostics10.1002/anie.202112925 ↗
39. First demonstration of gold nanorods-mediated photodynamic therapeutic destruction of tumors via near infra-red light activation10.1002/smll.201302719 ↗
40. End group nonplanarization enhances phototherapy efficacy of A–D–A fused-ring photosensitizer for tumor phototherapy10.1021/acs.nanolett.3c00119 ↗
41. Supramolecular agents for combination of photodynamic therapy and other treatments10.1039/D1SC01125A ↗
42. Tongue cancer tailored photosensitizers for NIR-II fluorescence imaging guided precise treatment10.1016/j.nantod.2022.101550 ↗
43. Fabrication of a phototheranostic nanoplatform for single laser-triggered NIR-II fluorescence imaging-guided photothermal/chemo/antiangiogenic combination therapy10.1016/j.actbio.2022.08.013 ↗
44. Photothermally triggered copper payload release for cuproptosis-promoted cancer synergistic therapy